Rodolfo Passalacqua

Rodolfo Passalacqua

UNVERIFIED PROFILE

Are you Rodolfo Passalacqua?   Register this Author

Register author
Rodolfo Passalacqua

Rodolfo Passalacqua

Publications by authors named "Rodolfo Passalacqua"

Are you Rodolfo Passalacqua?   Register this Author

71Publications

1678Reads

26Profile Views

Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world series.

Crit Rev Oncol Hematol 2019 Aug 21;140:80-87. Epub 2019 May 21.

Karolinska University Hospital, Eugeniavägen 3, PO Bäckencancer, Theme Cancer, Solna 17176, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2019.05.006DOI Listing
August 2019

Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data.

Ther Adv Med Oncol 2019 4;11:1758835919853954. Epub 2019 Jun 4.

Oncology Unit, Oncology Department, ASST of Cremona, Hospital of Cremona, Viale Concordia, 1, Cremona CR, 26100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835919853954DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552345PMC
June 2019

Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis.

Gastric Cancer 2019 03 27;22(2):245-254. Epub 2018 Nov 27.

Oncology Unit, Oncology Department, ASST Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-018-0901-3DOI Listing
March 2019

Biliary tract cancer: current challenges and future prospects.

Cancer Manag Res 2019 28;11:379-388. Epub 2018 Dec 28.

Department of Oncology, Operative Unit of Oncology, Azienda Socio Sanitaria Territoriale of Bergamo Ovest, Treviglio, Bergamo, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S157156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314055PMC
December 2018

Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches.

Cell Mol Life Sci 2018 Nov 1;75(22):4151-4162. Epub 2018 Sep 1.

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-018-2906-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182336PMC
November 2018

MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours.

Target Oncol 2018 08;13(4):423-436

Centre for Molecular Pathology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-018-0580-3DOI Listing
August 2018

Association of CDX2 Expression With Survival in Early Colorectal Cancer: A Systematic Review and Meta-analysis.

Clin Colorectal Cancer 2018 06 15;17(2):97-103. Epub 2018 Feb 15.

Oncology Unit, Oncology Department, ASST Bergamo Ovest, Treviglio, Bergamo, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2018.02.001DOI Listing
June 2018

Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature.

Breast Cancer Res Treat 2017 Nov 31;166(2):339-349. Epub 2017 Jul 31.

Oncology Unit, Oncology Department, ASST Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4419-xDOI Listing
November 2017

Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials.

HPB (Oxford) 2017 11 29;19(11):944-950. Epub 2017 Jul 29.

Oncology Unit, Oncology Department, ASST Bergamo Ovest, Piazzale Ospedale 1, 24047, Treviglio, BG, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hpb.2017.07.005DOI Listing
November 2017

Clinical development of mTor inhibitors for renal cancer.

Expert Opin Investig Drugs 2017 Nov 3;26(11):1229-1237. Epub 2017 Oct 3.

b Oncology Unit, Oncology Department , ASST Bergamo Ovest , Treviglio , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2017.1384813DOI Listing
November 2017

Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies.

Ann Surg Oncol 2017 Sep 15;24(9):2655-2668. Epub 2017 Mar 15.

Oncology Unit, Oncology Department, ASST Ospedale di Cremona, Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-5832-4DOI Listing
September 2017

Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.

HPB (Oxford) 2017 09 3;19(9):741-748. Epub 2017 Jul 3.

Oncology Unit, Oncology Department, ASST Bergamo Ovest, Treviglio, BG, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hpb.2017.05.010DOI Listing
September 2017

Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?

Eur J Cancer 2017 07 8;79:149-151. Epub 2017 May 8.

Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.008DOI Listing
July 2017

FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis.

JAMA Oncol 2017 Jul 13;3(7):e170278. Epub 2017 Jul 13.

Oncology Unit, Oncology Department, Azienda Socio Sanitaria Territoriale di Bergamo Ovest, Treviglio (Bergamo), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.0278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824228PMC
July 2017

Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer.

Expert Rev Clin Pharmacol 2017 Jun 10;10(6):649-660. Epub 2017 Apr 10.

b Oncology Unit, Oncology Department , ASST Bergamo Ovest , Treviglio (BG) , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2017.1313112DOI Listing
June 2017

Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review.

Med Oncol 2017 Apr 18;34(4):62. Epub 2017 Mar 18.

Oncology Unit, Oncology Department, ASST di Cremona, Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-017-0919-0DOI Listing
April 2017

Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicity.

Anticancer Drugs 2017 02;28(2):133-141

aOncology Unit, Department of Oncology, ASST Bergamo Ovest, Treviglio (BG) bOncology Unit, Department of Oncology, ASST Ospedale di Cremona, Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000436DOI Listing
February 2017

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

N Engl J Med 2016 Aug;375(8):717-29

From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1602253DOI Listing
August 2016

Targeted therapies in gastric cancer treatment: where we are and where we are going.

Invest New Drugs 2016 06 12;34(3):378-93. Epub 2016 Feb 12.

Oncology Division, Azienda Socio Sanitaria Territoriale di Cremona, Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0330-2DOI Listing
June 2016

Feasibility of a quality improvement strategy integrating psychosocial care into 28 medical cancer centers (HuCare project).

Support Care Cancer 2016 Jan 10;24(1):147-155. Epub 2015 May 10.

Research and Innovation Unit, University Hospital of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-015-2756-zDOI Listing
January 2016

Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).

J Immunother 2014 Nov-Dec;37(9):440-7

*Oncology Unit, Istituti Ospitalieri di Cremona, Cremona †Research and Innovation Unit ‡Medical Oncology Unit ¶Department of Clinical Medicine, Nephrology and Health Sciences, University Hospital of Parma, Parma §Medical Oncology Unit, IRCCS San Matteo University Hospital Foundation, Pavia ∥"Infrastructure Research and Statistics" Department, IRCCS-Arcispedale Santa Maria Nuova of Reggio Emilia, Reggio Emilia #Department of Oncology, Ospedali Riuniti di Bergamo, Bergamo **Oncology Unit, Arcispedale S. Maria Nuova di Reggio Emilia, Reggio Emilia ††Department of Oncology, University Hospital of Modena ‡‡Department of Oncology, Bolognini Hospital of Seriate, Alzano Lombardo §§Institute of Clinical Oncology, Carpi Hospital, Modena ∥∥Urology Unit, Vaio Hospital, Fidenza ¶¶Medical Oncology Unit, Hospital of Guastalla, Guastalla, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000055DOI Listing
November 2015

Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial.

Future Oncol 2014 ;10(9):1549-57

Oncology Division, Istituti Ospitalieri di Cremona, Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.106DOI Listing
April 2015

Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy.

Cancers (Basel) 2014 Sep 30;6(4):2035-48. Epub 2014 Sep 30.

Oncology Unit, Azienda Istituti Ospitalieri di Cremona, Largo Priori, 1, 26100 Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers6042035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276955PMC
September 2014

Pituitary gland metastasis from rectal cancer: report of a case and literature review.

Springerplus 2013 Sep 16;2:467. Epub 2013 Sep 16.

Oncology Division, Azienda Istituti Ospitalieri di Cremona, Viale Concordia 1, Cremona, 26100 Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2193-1801-2-467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786068PMC
September 2013

When a thymic carcinoma "becomes" a GIST.

Lung Cancer 2013 Apr 1;80(1):106-8. Epub 2013 Feb 1.

Department of Medical Oncology, Istituti Ospitalieri of Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.01.003DOI Listing
April 2013

First-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer : analysis of the Italian patients enrolled in the SAiL study.

Clin Drug Investig 2012 Nov;32(11):755-60

Department of Medical Oncology, National Cancer Institute, via Franco Gallini 2, 33081, Aviano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-012-0001-9DOI Listing
November 2012

A new modified schedule of sunitinib for metastatic renal cell carcinoma: a retrospective analysis.

Acta Biomed 2012 Aug;83(2):88-94

Oncology Division, Azienda Istituti Ospitalieri di Cremona, Cremona, Italy.

View Article

Download full-text PDF

Source
August 2012

Immunotherapy options in metastatic renal cell cancer: where we are and where we are going.

Expert Rev Anticancer Ther 2006 Oct;6(10):1459-72

Istituti Ospitalieri, Department of Internal Medicine, Medical Oncology Division, Viale Concordia 1, 26100, Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.10.1459DOI Listing
October 2006

Pancreatic carcinoma recurrence in the remnant pancreas after a pancreaticoduodenectomy.

JOP 2006 Sep 10;7(5):473-7. Epub 2006 Sep 10.

Department of Surgery and Transplantation, University of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
September 2006

How to promote, improve and test adherence to scientific evidence in clinical practice.

BMC Health Serv Res 2005 Sep 19;5:62. Epub 2005 Sep 19.

Epidemiology Service, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci, 14, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6963-5-62DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1253511PMC
September 2005

"Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen.

Acta Biomed 2004 Aug;75(2):126-30

Department of Clinical Medicine, Nephrology and Health Science, University of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
August 2004